Epilepsy treatment in sub-Saharan Africa: Closing the gap

African Health Sciences

Volumn 12, Issue 2, 2012, Pages 186-192

  Chin, J H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Africa; Anti epileptic; Epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

AFRICA SOUTH OF THE SAHARA; ARTICLE; CULTURAL ANTHROPOLOGY; DEMOGRAPHY; DRUG COST; EPILEPSY; EQUIPMENT; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH SERVICE; HUMAN; PATIENT CARE; PERSONNEL SHORTAGE; PREVALENCE; SOCIAL STIGMA; WORLD HEALTH ORGANIZATION;

AFRICA SOUTH OF THE SAHARA; ANTICONVULSANTS; EPILEPSY; HEALTH CARE COSTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY HEALTH CARE;

EID: 84864363726     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v12i2.17     Document Type: Article

References (42)

1. Leonardi M and Ustun TB. The global burden of epilepsy. Epilepsia. 2002;43:21-25.
2. World Health Organization. The global burden of disease-2004 update. WHO, Geneva; 2008.
3. World Health Organization. Atlas: country resources for neurological disorders 2004. WHO, Geneva; 2004.
4. World Health Organization. Neurological Disorders: Public Health Challenges. WHO, Geneva; 2006.
5. World Health Organization. Atlas: epilepsy care in the world. WHO, Geneva; 2005.
6. Preux P-M and Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub- Saharan Africa. Lancet Neurology. 2005;4:21-31.
7. Tekle-Haimanot R, Forsgren L, Abebe M, Gebre-Mariam A, Heijbel J, Holmgren G, et al. Electroencephalographic characteristics of epilepsy in rural Ethiopia: a community-based study. Epilepsy Res. 1990;7:230-239.
8. Osuntokun BO, Adeuja AOG, Nottidge VA, Bademosi O, Olumide A, Ige O, et al. Prevalence of the epilepsies in Nigerian Africans: a community-based study. Epilepsia. 1987;28:272-279.
9. Rwiza HT, Kilonzo GP, Haule J, Matuja WBP, Mteza I, Mbena P, et al. Prevalence and incidence of epilepsy in Ulanga, a rural Tanzanian district: a community-based study. Epilepsia. 1992;33:1051-1056.
10. Birbeck GL and Kalichi EMN. Epilepsy prevalence in rural Zambia: a door-to-door survey. Trop Med Intl Health. 2004;9:92-95.
11. Edwards T, Scott AG, Munyoki G, Mung'ala Odera V, Chengo E, Bauni E, et al. Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors. Lancet Neurology. 2008;7:50-56.
12. Simms V, Atijosan O, Kuper H, Nuhu A, Rischewski D, Lavy C. Prevalence of epilepsy in Rwanda: a national cross-sectional survey. Trop Med Intl Health. 2008;13:1047-1053.
13. Yemadje L-C, Houinato D, Quet F, Druet-Cabanac M, Preux P-M. Understanding the differences in prevalence of epilepsy in tropical regions. Epilepsia. 2011;52:1376-1381.
14. Meinardi H, Scott RA, Reis R, Sander JWAS. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia. 2001;42:136-149.
15. Kale R. The treatment gap. Epilepsia. 2002;43:31-33.
16. Meyer A-C, Dua T, Ma J, Saxena S, and Birbeck G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ. 2010;88:260-266.
17. Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in developing countries: A systematic review of the magnitude, causes, and intervention strategies. Epilepsia. 2008;49:1491-1503
18. Guinhouya KM, Aboki A, Kombaté D, Kumako V, Apétsé K, Belo M, et al. The epilepsy treatment gap in six primary care centres in Togo (2007-2009). Cahiers Santé. 2010;20: 93-99.
19. Shibre T, Alem A, Tekle-Haimanot R, Medhin G, Jacobsson L. Perception of stigma in people with epilepsy and their relatives in Butajira, Ethiopia. Ethiop J Health Dev. 2006;20:170-176.
20. Berhanu S, Alemu S, Prevett M, Parry EHO. Primary care treatment of epilepsy in rural Ethiopia: causes of default from follow-up. Seizure. 2009;18:100-103.
21. Chisholm D. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis. Epilepsia. 2005;46:751-759.
22. Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HGM, and Laing RO. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ. 2011;89:412-421.
23. Laroche ML, Traore H, Merle L, Gaulier J-M, Viana M, and Preux P-M. Quality of phenobarbital solid-dosage forms in the urban community of Nouakchott (Mauritania). Epilepsia.2005;46:1293-1296.
24. Morris J and Stevens P. Counterfeit medicines in less developed countries: problems and solutions. International Policy Network, London; 2006.
25. Owolabi MO, Bower JH, Ogunniyi A. Mapping Africa's way into prominence in the field of neurology. Arch Neurol. 2007;64:1696-1700.
26. Idro R, Newton C, Kiguli S, Kakooza-Mwesige A. Child neurology practice and neurological disorders in East Africa. J Child Neurol. 2010; 25:518-524.
27. Carpio A, Bharucha NE, Jallon P, Beghi E, Campostrini R, Zorzetto S, et al. Mortality of epilepsy in developing countries. Epilepsia. 2005;46(s11):28-32.
28. Birbeck GL, Chomba E, Atadzhanov M, Mbewe E, Haworth A. The social and economic impact of epilepsy in Zambia: a cross-sectional study. Lancet Neurology. 2007;6:39-44.
29. World Health Organization. Epilepsy in the WHO African region: bridging the gap. WHO, Geneva; 2004.
30. Scott RA, Lhatoo SD, Sander JWAS. Policy and Practice - The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ. 2011;79:344-351.
31. Wang WZ, Wu JZ, Ma GY, Dai XY, Yang B, Wang TP, et al. Efficacy assessment of phenobarbital in epilepsy: a large community based intervention trial in rural China. Lancet Neurol. 2006;5:46-52.
32. Kamgno J, Pion SDS, Boussinesq M. Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon. Epilepsia. 2003;44:956-963.
33. Nsengiyumva G, Druet-Cabanac M, Nzisabira L, Preux P-M, Vergnenegre A. Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study. Epilepsia. 2004;45:673-677.
34. Wilmhurst JM, van Toorn R. Use of phenobarbitone for treating childhood epilepsy in resource-poor countries. SAMJ. 2005;95:392-395.
35. Mbuba CK and Newton CR. Packages of care for epilepsy in low- and middle-income countries. PLoS Med. 2009; 6:1-7.
36. Kirigia JM, Gbary AR, Nyoni J, Seddoh A, Muthuri LK. The cost of health-related brain drain to the WHO African Region. Afr J Health Sci. 2006;13:1-12.
37. The Lancet Neurology. A new voice for global neurology? Lancet Neurology. 2010;9:1.
38. Hagopian A, Zuyderduin A, Kyobutungi N, Yumkella F. Job satisfaction and morale in the Ugandan health workforce. Health Affairs. 2009;28:w863-w875.
39. The Lancet Neurology. Neurology in sub-Saharan Africa - WHO cares? Lancet Neurology. 2006;5:637.
40. World Health Organization. mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings. WHO, Geneva; 2010.
41. Bristol N. Slow going for the Global Health Initiative. Health Affairs. 2011;30:1007-1009
42. Geneau R, Stuckler D, Stachenko S, McKee M, Ebrahim S, Basu S, et al. Raising the priority of preventing chronic diseases: a political process. Lancet. 2010;376:1689-1698.